Xponential Fitness (XPOF) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Xponential Fitness (XPOF) reported mixed Q2 2025 results, with revenue of $76.21 million missing estimates by 1.23% and declining 0.4% year-over-year. Although EPS of $0.26 significantly beat consensus and turned positive, a critical miss was in same-store sales, which came in at 1% versus the 3.9% analyst estimate, alongside a notable 26.4% decline in equipment revenue. Despite the stock's recent outperformance, it carries a Zacks Rank #4 (Sell), signaling potential near-term underperformance.

Analysis

Xponential Fitness (XPOF) reported a mixed financial performance for its second quarter of 2025, characterized by a significant earnings beat but concerning weakness in top-line growth and key operational metrics. Revenue of $76.21 million represented a slight year-over-year decline of 0.4% and missed the Zacks Consensus Estimate by 1.23%. In contrast, earnings per share of $0.26 were a notable positive, turning around from a loss of $0.03 in the prior-year period and surpassing consensus estimates by a substantial 36.84%. However, a deeper look into the company's health reveals critical weaknesses. Same-store sales, a key indicator of organic growth, grew by only 1%, falling significantly short of the 3.9% average analyst estimate. Furthermore, equipment revenue experienced a sharp 26.4% year-over-year contraction, suggesting a potential slowdown in new studio build-outs or upgrades. While the core franchise revenue stream posted a 5.4% YoY increase, it still narrowly missed expectations. Despite the stock's recent outperformance of +3.6% over the past month, the underlying fundamentals, coupled with a Zacks Rank #4 (Sell), signal potential for near-term underperformance.

Key Decisions for Investors

• Investors should exercise caution, as the significant miss on same-store sales (1% actual vs. 3.9% estimate) and the 26.4% YoY decline in equipment revenue point to a potential deceleration in organic growth and franchise expansion.
• The strong EPS beat should be weighed against the top-line revenue miss and weakening operational metrics, as current profitability may be challenged if negative revenue trends persist.
• Given the stock's recent outperformance relative to the broader market, the current Zacks Rank #4 (Sell) rating suggests the market may not have fully priced in the fundamental weaknesses, indicating a potential risk of near-term price correction.